Reversible lipidization for the oral delivery of leu-enkephalin

Author： Wang Jeffrey Hogenkamp Derk J. Tran Minhtam Li Wen-Yen Yoshimura Ryan F. Johnstone Timothy B. C. Shen Wei-Chiang Gee Kelvin W.

Publisher： Informa Healthcare

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.14, Iss.3, 2006-04, pp. : 127-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

N-terminal 4-imidazolidinone prodrugs of Leu-enkephalin: synthesis, chemical and enzymatic stability studies

By Bak A. Fich M. Larsen B.D. Frokjaer S. Friis G.J.

European Journal of Pharmaceutical Sciences, Vol. 7, Iss. 4, 1999-03 ,pp. : 317-323

Elsevier

Access to resources Recommend Favorite

Reversible Lipidization Prolongs the Pharmacological Effect, Plasma Duration, and Liver Retention of Octreotide

By Yuan Liyun Wang Jeff Shen Wei-Chiang

Pharmaceutical Research, Vol. 22, Iss. 2, 2005-02 ,pp. : 220-227

Springer Publishing Company

Access to resources Recommend Favorite

Reversal by [d-Ala 2 ,d-Leu 5 ]enkephalin of the dopamine transporter loss caused by methamphetamine

By Tsao L.-I. Cadet J.L. Su T.-P.

European Journal of Pharmacology, Vol. 372, Iss. 3, 1999-05 ,pp. : 5-7

Elsevier

Access to resources Recommend Favorite

Chronic [d-Ala 2 , d-Leu 5 ]enkephalin treatment increases the nerve growth factor in adult mouse brain

By Hayashi T. Su T.-P.

European Journal of Pharmacology, Vol. 464, Iss. 2, 2003-03 ,pp. : 237-239

Elsevier

Access to resources Recommend Favorite

[Met 5 ]enkephalin-Arg-Gly-Leu-induced antinociception is greatly increased by peptidase inhibitors

By Kanai M. Takahashi S. Kosaka K. Iwao K. Kobayashi H. Oka T.

European Journal of Pharmacology, Vol. 453, Iss. 1, 2002-10 ,pp. : 53-58

Elsevier

Access to resources Recommend Favorite